Type III collagen is found in most connective tissues, but is not found in hyaline cartilage. However, a unique type III collagen-related RNA has been detected in chick cartilage. This 3800 base RNA is much smaller than the authentic 5700 nucleotide type III collagen mRNA, and is in fact too small to encode a normal type III collagen subunit. Exons 21-52 of this RNA are similar or identical to the authentic type III collagen mRNA, but exons 1-16 appear to be missing from the 5' end of the RNA, suggesting that there may be an alternative transcription start site in the type III collagen gene which is used preferentially in cartilage. The absence of type III collagen in cartilage is presumably due to the altered RNA structure. Experiments are proposed to determine the structure of the type III collagen-related RNA and compare it with the authentic type III collagen mRNA. The 5' end of the chick type III collagen gene will also be isolated, and the promoter(s) and any previously undescribed exons will be identified by comparison of the exon/intron organization with the sequences of both the authentic type III collagen mRNA and the type III collagen-related RNA. These experiments will indicate whether the structural differences in the cartilage RNA are due to use of an alternative promoter, alternative RNA processing events, or both. They will also define any open reading frames in the RNA, thus indicating whether the RNA is likely to encode a protein (either a non-collagen protein or an altered form of type III collagen). The cis-acting sequences and trans-acting factors that are important for the function of the promoter(s) of the type III collagen gene in the appropriate tissues will be identified. Finally, the function of the cartilage type III collagen-related RNA will be determined. If, based on sequence and subcellular distribution data, the type III collagen-related RNA appears to encode a protein, the protein will be isolated and characterized. These experiments will provide increased understanding of the molecular mechanisms preventing production of type III collagen in cartilage, and will provide more extensive analysis of the structure of the type III collagen gene and its regulation than has heretofore been available. These studies on type III collagen gene expression, together with ongoing studies of alpha2(I) collagen gene expression, suggest the intriguing possibility that there may be a subset of collagen genes that encode alternative forms of mRNA in cartilage.

Project Start
Project End
Budget Start
Budget End
Support Year
20
Fiscal Year
1996
Total Cost
Indirect Cost
Myers, Jeanne C; Amenta, Peter S; Dion, Arnold S et al. (2007) The molecular structure of human tissue type XV presents a unique conformation among the collagens. Biochem J 404:535-44
Shahan, Tracy; Grant, Derrick; Tootell, Mason et al. (2004) Oncothanin, a peptide from the alpha3 chain of type IV collagen, modifies endothelial cell function and inhibits angiogenesis. Connect Tissue Res 45:151-63
Myers, Jeanne C; Li, Deqin; Amenta, Peter S et al. (2003) Type XIX collagen purified from human umbilical cord is characterized by multiple sharp kinks delineating collagenous subdomains and by intermolecular aggregates via globular, disulfide-linked, and heparin-binding amino termini. J Biol Chem 278:32047-57
Fawzi, A; Robinet, A; Monboisse, J C et al. (2000) A peptide of the alpha 3(IV) chain of type IV collagen modulates stimulated neutrophil function via activation of cAMP-dependent protein kinase and Ser/Thr protein phosphatase. Cell Signal 12:327-35
Shahan, T A; Fawzi, A; Bellon, G et al. (2000) Regulation of tumor cell chemotaxis by type IV collagen is mediated by a Ca(2+)-dependent mechanism requiring CD47 and the integrin alpha(V)beta(3). J Biol Chem 275:4796-802
Pasco, S; Han, J; Gillery, P et al. (2000) A specific sequence of the noncollagenous domain of the alpha3(IV) chain of type IV collagen inhibits expression and activation of matrix metalloproteinases by tumor cells. Cancer Res 60:467-73
Shahan, T A; Ohno, N; Pasco, S et al. (1999) Inhibition of tumor cell proliferation by type IV collagen requires increased levels of cAMP. Connect Tissue Res 40:221-32
Shahan, T A; Ziaie, Z; Pasco, S et al. (1999) Identification of CD47/integrin-associated protein and alpha(v)beta3 as two receptors for the alpha3(IV) chain of type IV collagen on tumor cells. Cancer Res 59:4584-90
Han, J; Jenq, W; Kefalides, N A (1999) Integrin alpha2beta1 recognizes laminin-2 and induces C-erb B2 tyrosine phosphorylation in metastatic human melanoma cells. Connect Tissue Res 40:283-93
Zhang, Y; Niu, Z; Cohen, A J et al. (1999) The internal chondrocyte-specific promoter of the chick type III collagen gene is activated by AP1 and is repressed in fibroblasts by a complex containing an LBP1-related protein. Nucleic Acids Res 27:4090-9

Showing the most recent 10 out of 93 publications